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Abstract
Background: The COSMIN checklist (COnsensus-based Standards for the selection of health status Measurement
INstruments) was developed in an international Delphi study to evaluate the methodological quality of studies on
measurement properties of health-related patient reported outcomes (HR-PROs). In this paper, we explain our
choices for the design requirements and preferred statistical methods for which no evidence is available in the
literature or on which the Delphi panel members had substantial discussion.
Methods: The issues described in this paper are a reflection of the Delphi process in which 43 panel members
participated.
Results: The topics discussed are internal consistency (relevance for reflective and formative models, and
distinction with unidimensionality), content validity (judging relevance and comprehensiveness), hypotheses testing
as an aspect of construct validity (specificity of hypotheses), criterion validity (relevance for PROs), and
responsiveness (concept and relation to validity, and (in) appropriate measures).
Conclusions: We expect that this paper will contribute to a better understanding of the rationale behind the
items, thereby enhancing the acceptance and use of the COSMIN checklist.
Background
For the measurement of health-related patient-reported
outcomes (HR-PROs) it is important to evaluate the
methodological quality of studies in which the measure-
ment properties of these instruments are assessed.
When studies on measurement properties have good
methodological quality, their conclusions are more trust-
worthy. A checklist containing standards for design
requirements and preferred statistical methods is a use-
ful tool for this purpose. However, there is not much
empirical evidence for the content of such a tool. A Del-
phi study is a useful study design in fields lacking
empirical evidence. It is particularly valued for its ability
to structure and organize group communication [1].
In an international Delphi study we developed the
COSMIN (COnsensus-based Standards for the selection
of health status Measurement INstruments) checklist for
evaluating the methodological quality of studies on mea-
surement properties [2,3]. The checklist contains twelve
boxes. Ten boxes can be used to assess whether a study
meets the standards for good methodological quality.
Nine of these boxes contain standards for the included
measurement properties (internal consistency, reliability,
measurement error, content validity (including face
validity), structural validity, hypotheses testing, and
cross-cultural validity (these three are aspects of con-
struct validity), criterion validity, and responsiveness),
and one box contains standards for studies on interpret-
ability. In addition, two boxes are included in the
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any medium, provided the original work is properly cited.checklist that contain general requirements for articles
in which IRT methods are applied (IRT box), and gen-
eral requirements for the generalisability of the results
(Generalisability box), respectively. More information on
how to use the COSMIN checklist can be found else-
where [4].
The checklist can be used, for example, in a systematic
review of measurement properties, in which the quality
of studies on measurement properties of instruments
with a similar purpose are assessed, and results of those
studies are compared with a view to select the best
instrument. If the results of high-quality studies differ
from the results of low-quality studies, this can be an
indication of bias. Consequently, instrument selection
should be based on the high-quality studies. The COS-
MIN checklist can also be used as guidance for designing
or reporting a study on measurement properties. Further-
more, students can use the checklist when learning about
measurement properties, and reviewers or editors of
journals can use it to appraise the methodological quality
of studies on measurement properties. Note that the
COSMIN checklist is not a checklist for the evaluation of
the quality of a HR-PRO, but for the methodological
quality of studies on their measurement properties.
As a foundation for the content of the checklist, we
developed a taxonomy of all included measurement
properties, and reached international consensus on ter-
minology and definitions of measurement properties [5].
The focus of the checklist is on studies on measurement
properties of HR-PROs used in an evaluative applica-
tion, i.e. longitudinal assessment of treatment effects or
changes in health over time.
In this paper, we provide a clarification for some parts
of the COSMIN checklist. We explain our choices for
the included design requirements and preferred statisti-
cal methods for which no evidence is available in the lit-
erature or which generated substantial discussion among
the members of the Delphi panel. The topics that are
subsequently discussed in detail are internal consistency,
content validity, hypotheses testing as an aspect of con-
struct validity, criterion validity, and responsiveness.
Internal Consistency
Internal consistency was defined as the interrelatedness
among the items [5]. In Figure 1 its standards are given.
The discussion was about the relevance of internal con-
sistency for reflective models and formative models, and
on the distinction between internal consistency and
unidimensionality.
The Delphi panel reached consensus that the internal
consistency statistic only gets an interpretable meaning,
when (1) the interrelatedness among the items is
Figure 1 Box A. Internal consistency.
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tive model, and (2) all items tap the same construct, i.e.,
they form a unidimensional (sub)scale [6,7].
A reflective model is a model in which all items are a
manifestation of the same underlying construct [8,9].
These items are called effect indicators and are expected
to be highly correlated and interchangeable [9]. Its
counterpart is a formative model, in which the items
together form a construct [8]. These items do not need
to be correlated. Therefore, internal consistency is not
relevant for items that form a formative model. For
example, stress could be measured by asking about the
occurrence of different situations and events that might
lead to stress, such as job loss, death in a family, divorce
etc. These events obviously do not need to be corre-
lated, thus internal consistency is not relevant for such
an instrument. Often, authors do not explicitly describe
whether their HR-PRO is based on a reflective or forma-
tive model. To decide afterwards which model was used,
o n ec a nd oas i m p l e“thought test”.W i t ht h i st e s to n e
should consider whether all item scores are expected to
change when the construct changes. If yes, a reflective
model is at issue. If not, the HR-PRO instrument is
probably based on a formative model [8].
For an internal consistency statistic to get an interpre-
table meaning the scale needs to be unidimensional.
Unidimensionality of a scale can be investigated with e.
g. a factor analysis, but not with an assessment of inter-
nal consistency [8]. Rather, unidimensionality of a scale
is a prerequisite for a clear interpretation of the internal
consistency statistics [6,7].
Content validity
Content validity was defined as the degree to which the
content of a HR-PRO instrument is an adequate
reflection of the construct to be measured [5] (see
Figure 2 for its standards). The discussion was about
how to evaluate content validity.
The Delphi panel agreed that content validity should
be assessed by making a judgment about the relevance
and the comprehensiveness of the items. The relevance
of the items should be assessed by judging whether the
items are relevant for the construct to be measured
(D1), for the study population (D2), and for the purpose
of the HR-PRO (D3). When a new HR-PRO is devel-
oped, the focus and detail of the content of the instru-
ment should match the target population (D2). When
the instrument is subsequently used in another popula-
tion than the original target population for which it was
developed, it should be assessed whether all items are
relevant for this new study population (D2). For exam-
ple, a questionnaire measuring shoulder disability (i.e.,
the Shoulder Disability Questionnaire [10]) may include
the item “my shoulder hurts when I bring my hand
towards the back of my head”. When one decides to use
this questionnaire in a population of patients with wrist
problems to measure wrist disability, one could not sim-
ply change the word “shoulder” into “wrist” because this
item might not be relevant for patients with wrist pro-
blems. Moreover, an item like “Do you have difficulty
with the grasping and use of small objects such as keys
or pens?” [11] will probably not be included in a ques-
tionnaire for shoulder disability, while it is clearly rele-
vant to ask patients with wrist problems.
Experts, should judge the relevance of the items for
the construct (D1), for the patient population (D2), and
for the purpose (D3). Because the focus is on PROs
patients should be considered as experts when judging
the relevance of the items for the patient population
(D2). In addition, many missing observations on an item
Figure 2 Box D. Content validity (including face validity).
Mokkink et al. BMC Medical Research Methodology 2010, 10:22
http://www.biomedcentral.com/1471-2288/10/22
Page 3 of 8can be an indication that the item is not relevant for the
population, or it is ambiguously formulated.
To assess the comprehensiveness of the items (D4)
three aspects should be taken into account: the content
coverage of the items, the description of the domains,
and the theoretical foundation. The first two aspects
refer to the question if all relevant aspects of the con-
struct are covered by the items and the domains. The
theoretical foundation refers to the availability of a clear
description of the construct, and the theory on which it
is based. A part of this theoretical foundation could be a
description of how different constructs within a concept
are interrelated, like for instance as described in the
model of health status of Wilson and Cleary [12] or the
International Classification of Functioning, Disability
and Health (ICF) model [13]. An indication that the
comprehensiveness of the items was assessed could be
that patients or experts were asked whether they missed
items. Large floor and ceiling effects can be an indica-
tion that a scale is not comprehensive.
Construct validity
Construct validity is the degree to which the scores of
an HR-PRO instrument are consistent with hypotheses
(for instance with regard to internal relationships, rela-
t i o n s h i p st os c o r e so fo t h e ri n s t r u m e n t s ,o rd i f f e r e n c e s
between relevant groups) based on the assumption that
the HR-PRO instrument validly measures the construct
to be measured [5]. It contains three aspects, i.e. struc-
tural validity, which concerns the internal relation-
ships, hypotheses testing, and cross-cultural validity,
which both concern the relationships to scores of
other instruments, or differences between relevant
groups.
Hypotheses testing
The standards for hypotheses testing are given in Figure 3.
The discussion was about how specific the hypotheses that
are being formulated should be.
Hypotheses testing is an ongoing, iterative process
[14]. Specific hypotheses should include an indication of
the expected direction and magnitude of correlations or
differences. Hypotheses testing is about whether the
direction and magnitude of a correlation or difference is
similar to what could be expected based on the con-
struct(s) that are being measured. The more hypotheses
are being tested on whether the data correspond to a
priori formulated hypotheses, the more evidence is gath-
ered for construct validity.
Figure 3 Box F. Hypotheses testing.
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be tested should be formulated a priori (F4) about
expected mean differences between known groups or
expected correlations between the scores on the instru-
ment and other variables, such as scores on other
instruments, or demographic or clinical variables. The
expected direction (positive or negative) (F5) and mag-
nitude (absolute or relative) (F6) of the correlations or
differences should be included in the hypotheses (e.g.
[14-17]).
For example, an investigator may theorize that two
HR-PROs intended to assess the same construct should
correlate. Therefore, the investigator would test whether
the observed correlation equals the expected correlation
(e.g. > 0.70). The hypotheses may also concern the rela-
tive magnitude of correlations, for example “it is
expected that the score on measure A correlates higher
(e.g. 0.10 higher) with the score on measure B than with
the score on measure C”.
A hypothesis can also concern differences in scores
between groups. When assessing differences between
groups, it is less relevant whether these differences are
statistically significant (which depends on the sample
size) than whether these differences have the expected
magnitude. For example, an investigator may theorize
based on previous evidence that persons off work with
low back pain have more pain related disability than
persons working with low back pain. Accordingly, an
instrument measuring pain related disability would be
valid in this context if it is capable to distinguish these
two groups. However, it is preferable to specify a mini-
mally important between-group difference. The Delphi
panel recommended that p-values should be avoided in
the hypotheses, because it is not relevant to examine
whether correlations or differences statistically differ
from zero [18]. The size of the difference is more
important than significant differences between the
groups, since this is dependent on the number of sub-
jects in each group. Formal hypotheses testing is prefer-
able based using the expected magnitude of correlations
and differences, rather than p-values.
When hypotheses are formulated about expected rela-
tions with other instruments, these comparator instru-
ments should be appropriately described (F7). For
example, if the comparator instrument intends to mea-
sure physical activity (PA), it should be described which
construct exactly it aims to measure. Some PA instru-
ments aim to measure total energy expenditure, others
are focussed on duration of physical activities, on the
frequency of activities, or on type of activities [19]. Ide-
ally, the measurement properties of the comparator
instruments should have been assessed in the same lan-
guage version and the same patient population as is
used in the study.
Criterion validity
Criterion validity was defined as the degree to which the
scores of a HR-PRO instrument are an adequate reflec-
tion of a “gold standard” [5]. The criterion used should
be considered as a reasonable “gold standard” (H4). The
Delphi panel reached consensus that no gold standards
exist for HR-PRO instruments, and discussed whether
criterion validity should be mentioned at all in the COS-
MIN checklist. The panel decided that the only excep-
tion of a gold standard is when a shortened instrument
is compared to the original long version. In that case,
the original long version can be considered the gold
standard. Often, authors consider their comparator
instrument wrongly as a gold standard, for example
when they compare the scores of a new instrument to a
widely used instrument like the SF-36. When the new
instrument is compared to the SF-36, we consider it as
construct validation, and expected hypotheses about the
magnitude and direction of the correlation between
(subscales of) the instruments should be formulated and
tested.
Responsiveness
The discussion on responsiveness was about the concept
of responsiveness, (in)appropriate methods to evaluate
responsiveness, and its relationship with validity. In the
COSMIN study responsiveness was defined as the ability
of a HR-PRO instrument to detect change over time in
the construct to be measured [5]. Although the Delphi
panel wanted to discuss responsiveness as a separate
measurement property, the panel agreed that the only
difference between cross-sectional (construct and criter-
ion) validity and responsiveness is that validity refers to
the validity of a single score, and responsiveness refers
t ot h ev a l i d i t yo fac h a n g es c o r e[ 5 ] .T h e r e f o r e ,t h e
panel decided that the standards for responsiveness
should be analogue to the standards for construct and
criterion validity. Similarly as with criterion validity, it
was agreed that no gold standards exist for change
scores on HR-PROs, with the exception of change on
the original longer version of a HR-PRO that can be
considered a gold standard, when it is compared to
change on its shorter version.
Appropriate measures to evaluate responsiveness are
the same as those for hypotheses testing and criterion
validity, with the only difference that hypotheses should
focus on the change score of an instrument. For exam-
ple, De Boer et al. assessed responsiveness of the Low
Vision Quality of Life questionnaire (LVQOL) and the
Vision-Related Quality of Life Core Measure (VCM1) by
testing pre-specified hypotheses about the relations of
changes in the questionnaires with changes in other
measures in patient with irreversible vision loss [20].
They hypothesized, for example, that ‘the correlation of
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Visual Functioning questionnaire (VF-14) is higher than
the correlation with the global rating scale, change in
visual acuity and change on the Euroqol thermometer’.
After calculating correlations between the change scores
on the different measurement instruments they con-
cluded whether the correlations were as expected.
There are a number of parameters proposed in the lit-
erature to assess responsiveness that the Delphi panel
considers inappropriate. The panel reached consensus
that the use of effect sizes (mean change score/SD base-
line) [21], and related measures, such as standardised
response mean (mean change score/SD change score)




2 error) [23], and relative efficacy statistic ((t-
statistic1/t-statistic2)
2)[ 2 4 ]a r ei n a p p r o p r i a t em e a s u r e s
of responsiveness. The paired t-test was also considered
to be inappropriate, because it is a measure of signifi-
cant change instead of valid change, and it is dependent
o nt h es a m p l es i z eo ft h es t u d y[ 1 8 ] .T h e s em e a s u r e s
are considered measures of the magnitude of change
due to an intervention or other event, rather than mea-
sures of the quality of the measurement instrument
[25,26]. Guyatt’s responsiveness ratio (MIC/SD change
score of stable patients) [27] was also considered to be
inappropriate, because it takes the minimal important
change into account. The Delphi panel agreed that
minimal important change concerns the interpretation
of the change score, but not the validity of the change
score.
Discussion
In this article, we explained our choices for the design
requirements and preferred statistical methods for
which no evidence is available in the literature or which
generated major discussions among the members of the
Delphi study during the development of the COSMIN
checklist. However, within the four rounds of the Delphi
study, two issues could not be discussed extensively, due
to lack of time. These issues concerned factor analyses
(mentioned in Box A internal consistency and Box E
structural validity) and minimal important change (men-
tioned in Box J interpretability).
The Delphi panel decided that the evaluation of struc-
tural validity can be done either by explorative factor
analysis or confirmative factor analysis. However, confir-
matory factor analysis is preferred over explorative fac-
tor analysis, because confirmative factor analysis tests
whether the data fit an a priori hypothesized factor
structure [28], while explorative factor analysis can be
used when no clear hypotheses exist about the underly-
ing dimensions [28]. Such an explorative factor analysis
is not a strong tool in hypothesis testing. In the COS-
MIN study we did not discuss specific requirements for
factor analyses, such as the choice of the explorative fac-
tor analysis (principal component analysis or common
factor analysis), the choice and justification of the rota-
tion method (e.g. orthogonal or oblique rotation), or the
decision about the number of relevant factors. Such spe-
cific requirements are described by e.g. Floyd & Wida-
man [28] and De Vet et al. [29].
In the Delphi panel it was discussed that in a study
evaluating the interpretability of scores of an HR-PRO
instrument the minimal important change (MIC) or
minimal important difference (MID) should be deter-
mined. The MIC is the smallest change in score in the
construct to be measured which patients perceive as
important. The MID is the smallest differences in the
construct to be measured between patients that is consid-
ered important [30]. Since we talk about patient-reported
outcomes, the agreement among panel members was that
the patients should be the one to decide on what is
important. In the literature there is an ongoing discus-
sion about which methods should be used to determine
the MIC or MID of a HR-PRO instrument [31]. Conse-
quently, the opinions of the panel members differed
widely, and within the COSMIN study no consensus on
standards for assessing MIC could be reached.
The results of a Delphi study are dependent on the
composition of the panel. The panel members do not
need to be randomly selected to represent a target
population. Rather experts are chosen because of their
knowledge of the topic of interest [32,33]. It has been
noted that heterogeneous groups produce a higher pro-
portion of high-quality, highly acceptable solutions than
homogeneous groups [1]. Furthermore, anonymity of
each of the panel members is often recommended,
because it provides an equal chance for each panel
member to present and react to ideas unbiased by the
identities of other participants [34]. Both issues were
ensured in this Delphi study. We included experts in
the field of psychology, epidemiology, statistics and clin-
ical medicine. The panel members did not know who
the other panel members were. All questionnaires were
analysed and reported back anonymously. Only one of
the researchers (LM) had access to this information.
The COSMIN Delphi study focussed on assessing the
methodological quality of studies on measurement prop-
erties of existing HR-PROs. However, we think that the
discussions described above and the COSMIN checklist
itself are also relevant and applicable for researchers
who are developing HR-PROs. The COSMIN checklist
can be a useful tool for designing a study on measure-
ment properties.
Conclusions
In conclusion, as there is not much empirical evidence
for standards for the assessment of measurement
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appropriate method to develop a checklist on the meth-
odological quality of studies on measurement properties.
Within this Delphi study we have had many interesting
discussions, and reached consensus on a number of
important issues about the assessment of measurement
properties. We expect that this paper will contribute to
a better understanding of the rationale behind the items
in the COSMIN checklist, thereby enhancing its accep-
tance and use.
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